TELA Bio, Inc. (NASDAQ:TELA) Q4 2024 Earnings Call Transcript March 20, 2025
TELA Bio, Inc. beats earnings expectations. Reported EPS is $-0.23, expectations were $-0.24.
Operator: Good afternoon, ladies and gentlemen, and welcome to the TELA Bio Fourth Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the prepared remarks. As a reminder, this conference call is being recorded. I would now like to turn...




